1. Home
  2. News
  3. Recce Pharmaceuticals Ltd.
  4. Recce Signs Middle East Licensing Term Sheet
More Recce Pharmaceuticals Ltd. news
Recce Pharmaceuticals Ltd.ASX: RCE

Recce Signs Middle East Licensing Term Sheet

May 26, 2026 at 8:09 PM EDT · Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · May 26, 2026 at 8:09 PM EDT · 4 pages · English

On 6ix: 6ix.com/news/recce-signs-middle-east-licensing-term-sheet

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

  • Brazil Patent Granted for RECCE Anti-InfectivesMar 24
  • RCE Investor Webinar Presentation DeckMar 19
  • Appendix 4D and Interim Financial ReportFeb 27
  • Recce Enters Second U.S. Department of Defense R&D AgreementFeb 1
  • Quarterly Activities/Appendix 4C Cash Flow ReportJan 30

Later from Recce Pharmaceuticals

  • Addendum to Recce Signs Middle East Licensing Term SheetMay 27
  • HREC Approval Accelerates Global Phase 3 DFI StrategyJun 21
  • Placement & SPP to raise $8 millionJun 25
  • AUD $3.7M Income Tax Refund ReceivedJun 30
  • Vietnamese Patent Granted for RECCE Anti-InfectivesJul 13
All Recce Pharmaceuticals news releases↗

Follow Recce Pharmaceuticals into a list and get an email when it puts out news.

Follow Recce Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer